NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

A tradition enforced by FDA. FDA gives you a generic name and approves your proposed Brand name. The name cannot look or sound like something that has come before. FDA does not like when companies use and trademark a name before their approval of a name as this is called pre-market promotion.

Antigren was a well accepted trademarked name for the anti-integren drug that ultimately became known Tysabri (natalizumab) for example. FDA would not let Biogen keep the name that Elan gave it, everyone already knew and easily identified as the product and MOA.

It will not be called DCVax when it comes to market. They shouldn’t have chosen to name the product so generically as it begs other copycats to hitch their wagon to it. It would not have been hard for them to do a little research and see the writing on the wall. I don’t think it was a bad idea to brand the product pre-approval, but do think they should have put some more thought into ithe name they used. Rookie mistake.